Acute Respiratory Disease
8
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
25%
1 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
Estimation of P0.1 Using Ultrasound Indexes of Diaphragm Function
Positioning of Children With Acute Respiratory Insufficiency
Humidification Practices During Hospitalized Patients on Non-Invasive Ventilation
Study of the Use of Nasal IFN-γ in Patients for the Prevention of Acute Respiratory Viral Infections, Icluding COVID-19
Advanced Point-of-care Technology During In-home Assessment Among Older Adults
Study of Hospitalised Patients With Acute Respiratory Conditions
Effectiveness of the Pneumococcal Polysaccharide Vaccine in Military Recruits
Medication List in and Out of Hospital